Scarica l'app Stockscreener
1.40
4.44%
-0.065
Dopo l'orario di chiusura:
1.39
-0.01
-0.71%
Nexentis Technologies Inc Borsa (NXTS) Ultime notizie
Nexentis Technologies Inc. (NXTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nexentis Technologies Inc. (NXTS) stock price, news, quote and history - Yahoo Finance UK
Nexentis appoints computational chemistry expert to advisory board - Investing.com
Nexentis appoints computational chemistry expert to advisory board By Investing.com - Investing.com Nigeria
Nexentis Technologies Announces Appointment of Prof. Dan T. Major to MitoCareX Scientific Advisory Board - Quiver Quantitative
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board - GlobeNewswire
Nexentis subsidiary evaluates ways for obtaining proteins in in-vitro research - TipRanks
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery - The Manila Times
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities - GlobeNewswire
Nexentis Technologies Inc. (NASDAQ: NXTS) Share Price, NXTS Stock News, NXTS Share Price & Updates - kalkine.com.au
Top Nexentis Technologies (NXTS) Competitors 2026 - MarketBeat
NXTS Q2 2025 Earnings: Reported Per-Share Loss of $0.18 as Stock Edges Up 1.2%Return On Equity - dars.gov.et
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis Faces Nasdaq Delisting Over Equity Shortfall - Minichart
Nexentis Technologies Faces Nasdaq Compliance and Delisting Risk - TipRanks
Nexentis Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NXTS - Finviz
Nexentis Technologies Inc. (NXTS) Rises 5.98% to $1.95, Approaching Key Resistance at $2.05Hedge Fund Favorites - Vinanet
Nexentis Technologies (NXTS) flags going concern after $17.7M loss and $6.3M impairment - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexentis Technologies (NASDAQ: NXTS) changes auditors after prior going concern note - Stock Titan
Nexentis Technologies (NXTS) Gains 4% as Bullish Momentum Builds Toward Key $2.03 ResistanceIchimoku Entry - dars.gov.et
NXTS Q2 2025 Earnings: Loss of $0.18 Per Share Reported as Stock Climbs 10.32%Analyst Earnings Estimate - vinanet.vn
NXTS Q2 2025 Earnings: Reported Loss of -$0.18 Per Share, Yet Shares Jump 10.32%Profit Margin Analysis - careplusvn.com
Nexentis subsidiary selects candidate for drug discovery program By Investing.com - Investing.com Canada
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign - globenewswire.com
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Loss and Stock Decline Reflect Ongoing Challenges - dars.gov.et
Nexentis Technologies Inc. Revenue Breakdown – NASDAQ:NXTS - TradingView
Nexentis Technologies (NXTS) Drops 7%: Key Support Level in FocusElliott Wave Entry - dars.gov.et
NXTS Q2 2025 Earnings: Wider-than-expected loss drives shares down 7.86%Earnings Momentum Score - dars.gov.et
Nexentis Technologies Inc. SEC Filing (Jul 20, 2026) - Stock Titan
NXTS Q2 2025 Earnings: Reported Loss of $0.18 per Share Amid Market SelloffAnalyst Drop Coverage - dars.gov.et
Nexentis Technologies soars 156% before falling 46% after hours — here’s why NXTS stock is trending - MSN
Nexentis Technologies Inc. SEC Filing (Jul 16, 2026) - Stock Titan
Eun Young Lee holds 3.23% of Nexentis Technologies Inc. (NXTS) - Stock Titan
NXTS Q2 2025 Earnings: Wider-Than-Expected Loss Sends Shares LowerMargin Compression Risk - vinanet.vn
Nexentis Technologies files prospectus for 2.573M shares - scanx.trade
Nexentis Technologies (NASDAQ: NXTS) refreshes $100M shelf and details MitoCareX deal - Stock Titan
Nexentis Technologies registers to sell 2.57M shares of common stock for holders - TipRanks
Nexentis Technologies (NASDAQ: NXTS) registers 2.57M warrant shares for resale - Stock Titan
Nexentis Technologies Q2 2025 Earnings: Loss of -$0.18 Per Share Sends Stock Down 14.56%Energy Earnings Report - dars.gov.et
Nexentis Technologies (NXTS) Slides 4.5% as Selling Pressure Tests Key Support at $3.46Double EMA - dars.gov.et
NXTS Q2 2025 Earnings: Net Loss of $0.18 Per Share as Stock Slips 3.6%Earnings Quality Score - dars.gov.et
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative - The Manila Times
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter - GlobeNewswire
Nexentis Technologies Shares Gain 10% on Partial Monetisation of German Solar ProjectPreliminary Results - Vinanet
Nexentis stock jumps on solar project monetization deal - Investing.com
Nexentis Announces Monetization of Part of It - Moomoo
NXTS Q2 2025 Earnings: A Disappointing Quarter as Losses Widen and Shares TumbleEarnings Yield Spread - dars.gov.et
Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS) - Yahoo Finance
Nexentis Technologies announces monetization of Melz solar investment - TipRanks
Nexentis receives partial loan repayment on German solar project By Investing.com - Investing.com Nigeria
Nexentis receives partial loan repayment on German solar project - Investing.com
Nexentis stock jumps on solar project monetization deal By Investing.com - Investing.com Canada
2.25%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):